CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net Sales	$ 101,489	$ 83,612
Cost of Sales	84,005	74,908
Gross Profit	17,484	8,704
Research and Product Development	19	1,107
Selling and Marketing	2,749	2,125
General and Administrative	14,108	12,142
Operating Income (Loss)	608	(6,670)
Other Expense:
Realized Gain on Investments	74	321
Interest Expense	(1,254)	(2,301)
Interest Income	92	211
Total Other Expense, net	(1,088)	(1,769)
Net Loss	$ (480)	$ (8,439)
Net Loss Per Share Attributable to Common Stockholders - Basic (in dollars per share)	$ (0.03)	$ (0.37)
Net Loss Per Share Attributable to Common Stockholders - Diluted (in dollars per share)	$ (0.03)	$ (0.37)
Weighted Average Number of Shares of Common Stock Outstanding - Basic (in shares)	31,058,539	23,322,915
Weighted Average Number of Shares of Common Stock Outstanding - Diluted (in shares)	31,058,539	23,322,915